期刊文献+

胎儿经腹脐静脉穿刺术临床资料分析 被引量:7

The analysis of the cases underwent cordocentisis
下载PDF
导出
摘要 目的评价胎儿经腹脐静脉穿刺术的手术指征、方法及安全性。方法回顾性分析2012年1月至2014年12月在北京大学第一医院妇产科接受胎儿脐静脉穿刺术的303例病例的手术指征、方法及安全性。结果 91.8%(278/303)的患者手术指征为明确胎儿染色体核型。其中胎儿患有明显畸形的病例中10.5%(16/153)染色体核型异常。10例手术指征为羊膜腔穿刺的染色体核型为嵌合型或有标记物,脐血穿刺术后3例染色体核型正常,7例与羊膜腔穿刺结果相符。92.4%(280/303)的孕妇穿刺一次成功。脐血穿刺术后胎儿的总流失率为1.32%(4/303),术后2周之内的流失率为0.99%(3/303),胎心过缓率为3.0%(10/303)。结论脐血穿刺术是一个较安全的产前诊断手术,其指征可为明确胎儿染色体核型。但是急需新的实验室方法来探讨胎儿畸形的遗传学改变。 Objective To value the indications,methods and safety of the cordocentisis. Method Between January2012 and December 2014,303 cordocenteses were performed in 303 women with singleton pregnancy in the Peking University First Hospital. A 22-gauge percutaneous needle was used to puncture the umbilical vein at the relatively fixed position with the "free-armed"method. Result 91. 8%(278 /303) procedures were performed to identify the fetal karyotype. But only 10. 5%(16 /153) of the karyotypes of the fetuses with obvious abnormalities are abnormal.Three cases whose chromosomal karyotypes were mosaics by amniocentesis had normal karyotypes by cordocentesis.92. 4%( 280 /303) cases just needed one puncture. The gross fetal loss rate after cordocentesis was 1. 32%( 4 /303),and the fetal loss rate in two weeks was 0. 99%(3 /303),the fetal bradycardia rate was 3. 0%(10 /303).Conclusion Cordocentesis is a relatively safe prenatal surgery. The most important indications for the procedure should be the diagnosis and treatment for fetal anemia,and the identification for the karyotypes of the fetuese with chromosomal mosaic by amniocentesis,as well as the chromosome karyotype analysis. But new laboratory methods should be performed to investigate the genetic anomalies for the fetuses with structural abnormalities.
出处 《中国医刊》 CAS 2015年第7期32-36,共5页 Chinese Journal of Medicine
关键词 脐血穿刺 产前诊断 染色体核型 合并症 Cordocentesis Prenatal diagnosis Karyotype Complications
  • 相关文献

参考文献12

  • 1Ogur G,Giil D,Ozen S,et al.Application of the Apt test in prena- tal diagnosis to evaluate the fetal origin of blood obtained by cordo- centesis:result of 30 pregnancies[J].Prenat Diagn,1997,17(9):879-882.
  • 2Sepulveda W,Be C,Youlton R,et al.Accuracy of the haemoglobin alkaline denaturaton test for detecting maternal blood contamination of fetal blood samples for prenatal karyotyping[J].Prenat Diagn,1999,19(10):927-929.
  • 3Society for Maternal- Fetal Medicine(SMFM),Berry SM,Stone J,et al.Fetal blood sampling[J].Am J Obstet Gynecol,2013,209(3):170-180.
  • 4Weiner CP,Wenstrom KD,Sipes SL,et al.Risk factors for cordocen- tisis and fetal intravascular transfusion[J].Am J Obstet Gynecol,1991,165(4):1020-1025.
  • 5Paidas MJ,Berkowitz RL,Lynch L,et al.Alloimmune thrombocytope- nia:Fetal and neonatal losses related to cordocentisis[J].Am J Obstet Gynecol,1995,172(2):475-479.
  • 6Aina-Mumuney AJ,Hoicroft CJ,Blakemore KJ,et al.Intrahepatic vein for fetal blood sampling:one center's experience[J].Am J Obstet Gynecol,2008,198(4):387.
  • 7American College of Obstetricians and Gynecologists.Invasive pre- natal testing for aneuploidy.ACOG Practice Bulletin No.88[J].Obstet Gynecol,2007,110(6):1459-1467.
  • 8Maxwell DJ,Johnson P,Hurley P,et al.Fetal blood sampling an pregnancy loss in relation to indication[J].Br J Obstet Gynaecol,1991,98(9):892-897.
  • 9Antsaklis A,Daskalakis G,Papantoniou N,et al.Fetal blood sam- pling-indication-related losses[J].Prenat Diagn,1998,18(9):934-.
  • 10姜海利,张为远,王欣.超声筛查指标与染色体异常相关性的再探讨[J].中国医刊,2015,50(5):98-101. 被引量:5

二级参考文献18

  • 1李胜利.胎儿畸形产前超声诊断学[M].北京:人民军医出版社,2011.346.
  • 2张为远.中华围产医学[M].北京:人民卫生出版社,2012:247.
  • 3Pnu G, Nieolaides K, Ximenes R, et al. Ytagnogta af Fetal Abnormal-ities-The 18-23 weeks scan [M]. London:ISUOG & Fetal Medi-cine Fundation ,2002:8-21,28-52,64-80,95-97.
  • 4Enzensberqer C, Pulvermacher C, Deqenhardt J, et al. Fetal loss rate and associated risk factors after amniocentesis, chorionic villus sam-piing and fetal blood sampling [J]. Ultraschall Med, 2012,33 (7):e75-e79.
  • 5Nieolaides KH. Screening for chromosomal defects [J]. Ultrasound Obstet Gyneeol,2003(21):313-321.
  • 6Shipp TD, Benacerraf BR. Second trimester uhrasound screening for chromosomal abnormalities [J]. Prenat Diagn ,2002 (22):296-307.
  • 7Saucedo MC, DeVigan C, Vodovar V, et al. Measurement of nuchal translucency and the prenatal diagnosis of Down syndrome [J]. Ob-stet Gynecol,2009,114 (4):829-838.
  • 8Benaeerraf BR. The history of the second-trimester sonographic markers for detecting fetal Down syndrome, and their current role in obstetric practice [J]. Prenat Diagn ,2010 (30):644-652.
  • 9Nicolaides KH, Weqrzyn P. Increased nuchal translucency with nor-mal karyotype [J]. Ginekol Pol,2005,76 (8):593-601.
  • 10Westin M, Sultvedt S, Bergrnan G, et al. Routine ultrasound examina-tion at 12 or 18 gestational weeks for prenatal detection of major con-genital heart malformations? A randomised controlled trial compri-sing 36299 fetuses [J]. BJOG,2006,113 (3):675-682.

共引文献4

同被引文献43

引证文献7

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部